Lumexa Imaging Reports 7.9% Revenue Growth, 18.6% Adjusted EBITDA Increase
Lumexa Imaging’s fourth-quarter revenues rose 7.9% to $267.7 million with Adjusted EBITDA up 18.6% to $63.8 million and a 23.8% margin. The company cut leverage from 5.5x to 3.5x, saving over $50 million annually, and reiterated 2026 guidance for $1.045–1.097 billion revenue and $234–242 million EBITDA.
1. Fourth Quarter Financial Results
Lumexa Imaging delivered Q4 revenues of $267.7 million, up 7.9% year-over-year, with Adjusted EBITDA increasing 18.6% to $63.8 million, representing a 23.8% margin. The quarter saw same-center advanced imaging volume grow 12.7%, and net loss widen to $28.7 million from $25.1 million.
2. Full Year 2025 Highlights
For full year 2025, revenues reached $1.023 billion, up 7.8%, and Adjusted EBITDA rose 14.6% to $230.2 million, yielding a 22.5% margin. The company added ten new imaging facilities, including nine de novo centers, and reduced net loss to $47.1 million from $94.1 million.
3. 2026 Guidance and Strategic Priorities
Lumexa Imaging reiterated its 2026 outlook for revenues of $1.045–1.097 billion and Adjusted EBITDA of $234–242 million, factoring in $7 million in new public company costs. Management aims to drive growth through same-center expansion, geographic rollout, and advanced imaging services.